Funded articles
- Page Path
-
- HOME
- BROWSE ARTICLES
- Funded articles
-
Drug therapy and monitoring for inflammatory bowel disease: a multinational questionnaire investigation in Asia
-
Chenwen Cai, Juntao Lu, Lijie Lai, Dongjuan Song, Jun Shen, Jinlu Tong, Qing Zheng, Kaichun Wu, Jiaming Qian, Zhihua Ran
-
Intest Res. 2022;20(2):213-223. Published online April 29, 2022
-
-
Full text PubReader ePub Crossref - TDM PDF Supplementary Material
-
Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
-
Saurabh Kedia, Raju Sharma, Sudheer Kumar Vuyyuru, Deepak Madhu, Pabitra Sahu, Bhaskar Kante, Prasenjit Das, Ankur Goyal, Karan Madan, Govind Makharia, Vineet Ahuja
-
Intest Res. 2022;20(2):184-191. Published online May 4, 2021
-
-
Full text PubReader ePub Crossref - TDM PDF
-
Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity
-
Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Yoichi Kakuta, Hidezumi Kikuchi, Shogo Kawaguchi, Keisuke Hasui, Tetsuya Tatsuta, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda
-
Intest Res. 2022;20(1):90-100. Published online January 22, 2021
-
-
Full text PubReader ePub Crossref - TDM PDF Supplementary MaterialGraphic abstract
-
Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model
-
Jihye Park, Da Hye Kim, Soochan Kim, Hyun Woo Ma, I Seul Park, Mijeong Son, Ji Hyung Kim, Yoojin Shin, Seung Won Kim, Jae Hee Cheon
-
Intest Res. 2021;19(4):478-481. Published online October 26, 2021
-
-
Full text PubReader ePub Crossref - TDM PDF
- Inflammatory Bowel Diseases
-
Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
-
Taku Kobayashi, Hiroaki Ito, Toshifumi Ashida, Tadashi Yokoyama, Masakazu Nagahori, Tomoki Inaba, Mitsuhiro Shikamura, Takayoshi Yamaguchi, Tetsuharu Hori, Philippe Pinton, Mamoru Watanabe, Toshifumi Hibi
-
Intest Res. 2021;19(4):448-460. Published online August 18, 2020
-
-
Full text PubReader ePub Crossref - TDM PDF Supplementary Material
-
High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
-
Saransh Jain, Divya Namdeo, Pabitra Sahu, Saurabh Kedia, Peush Sahni, Prasenjit Das, Raju Sharma, Vipin Gupta, Govind Makharia, Lalit Dar, Simon PL Travis, Vineet Ahuja
-
Intest Res. 2021;19(4):438-447. Published online November 6, 2020
-
-
Full text PubReader ePub Crossref - TDM PDF Supplementary Material
- Inflammatory Bowel Diseases
-
Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
-
Shin Ju Oh, Ga Young Shin, Hosim Soh, Jae Gon Lee, Jong Pil Im, Chang Soo Eun, Kang-Moon Lee, Dong Il Park, Dong Soo Han, Hyo Jong Kim, Chang Kyun Lee
-
Intest Res. 2021;19(3):323-331. Published online August 18, 2020
-
-
Full text PubReader ePub Crossref - TDM PDF